Swine Flue Pandemic

Life Sciences

Elemer Piros, Ph.D. - Senior Biotechnology Analyst (212-430-1754)


Novavax Conference Call: Potential Swine Flu Pandemic – Novavax can Deliver

Click for Full PDF

Rodman & Renshaw
Invites you to join us for our latest in expert conference calls.

Elemer Piros, Ph.D.
Senior Biotechnology Analyst


Will Host


Swift Response to a Potential Swine Flu Pandemic – Novavax can Deliver

A Conversation with the CEO, Rahul Singhvi


The US declared public health emergency over the swine flu outbreak. More than 100 have died in Mexico. Cases were reported in Europe, New Zealand and in the United States (20; 8 of those in NYC). This variant of the flu may respond to antivirals Tamiflu & Relenza. Should it become resistant, or should it become more deadly, it may only be conquered with vaccination. Novavax is the only company that can deliver a vaccine in 3 months. Please join us for a timely discussion with the CEO.


The conference call will take place on
Tuesday, April 28, 2009
11:00am ET, 10:00am CT, 9:00am MT, 8:00am PT
Dial-In Number: (888) 600-4871, International Callers: (913) 312-0937
A replay will be available for one week starting at 2:00pm ET:
(888) 203-1112 or (719) 457-0820, Passcode: 5570740
To ensure a timely start, please dial in 5 to 10 minutes prior to start time.


For more information, please contact your Rodman & Renshaw, LLC sales representative.

Member FINRA, SIPC

Notice Regarding Privacy and Confidentiality:

Rodman & Renshaw, LLC reserves the right to monitor and review the content of all e-mail communications sent and/or received by its employees.

This material has been prepared for informational purposes only. While it is based on information generally available to the public from sources we believe to be reliable, no representation is made that the subject information is accurate or complete. Past performance is not a guarantee nor does it necessarily serve as an indicator of future results. Price and availability are subject to change without notice. Additional information is available upon request.

Since Rodman & Renshaw, LLC is not a tax advisor, transactions requiring tax consideration should be reviewed carefully with your tax advisor. Similarly, Rodman & Renshaw, LLC is not a law firm and provides no legal opinions or legal advice.

Rodman & Renshaw, LLC may make a market in the securities being discussed.

Rodman & Renshaw, LLC and/or its officers or employees may have positions in any of the securities of this (these) issuer(s).

Member FINRA.
Member SIPC.

REF:011707RR-MN